FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4322632076> ?p ?o ?g. }

• W4322632076 endingPage "103980" @default.
• W4322632076 startingPage "103980" @default.
• W4322632076 abstract "Naloxone distribution is central to ongoing efforts to address the opioid overdose crisis. Some critics contend that naloxone expansion may inadvertently promote high-risk substance use behaviors among adolescents, but this question has not been directly investigated.We examined relationships between naloxone access laws and pharmacy naloxone distribution with lifetime heroin and injection drug use (IDU), 2007-2019. Models generating adjusted odds ratios (aOR) and 95% confidence intervals (CI) included year and state fixed effects, controlled for demographics and sources of variation in opioid environments (e.g., fentanyl penetration), as well as additional policies expected to impact substance use (e.g., prescription drug monitoring). Exploratory and sensitivity analyses further examined naloxone law provisions (e.g., third-party prescribing) and applied e-value testing to assess vulnerability to unmeasured confounding.Adoption of any naloxone law was not associated with changes in adolescent lifetime heroin or IDU. For pharmacy dispensing, we observed a small decrease in heroin use (aOR: 0.95 [CI: 0.92, 0.99]) and a small increase in IDU (aOR: 1.07 [CI: 1.02, 1.11]). Exploratory analyses of law provisions suggested that third-party prescribing (aOR: 0.80, [CI: 0.66, 0.96]) and non-patient-specific dispensing models (aOR: 0.78, [CI: 0.61, 0.99]) were associated with decreased heroin use but not decreased IDU. Small e-values associated with the pharmacy dispensing and provision estimates indicate that unmeasured confounding may explain observed findings.Naloxone access laws and pharmacy naloxone distribution were more consistently associated with decreases rather than increases in lifetime heroin and IDU among adolescents. Our findings therefore do not support concerns that naloxone access promotes high-risk adolescent substance use behaviors. As of 2019, all US states have adopted legislation to improve naloxone access and facilitate use. However, further removal of adolescent naloxone access barriers is an important priority given that the opioid epidemic continues to affect people of all ages." @default.
• W4322632076 created "2023-03-01" @default.
• W4322632076 creator A5006572902 @default.
• W4322632076 creator A5015719024 @default.
• W4322632076 creator A5032703621 @default.
• W4322632076 creator A5037098623 @default.
• W4322632076 creator A5053391308 @default.
• W4322632076 creator A5062381819 @default.
• W4322632076 creator A5068626512 @default.
• W4322632076 creator A5076335292 @default.
• W4322632076 creator A5078795152 @default.
• W4322632076 creator A5080186393 @default.
• W4322632076 creator A5082420499 @default.
• W4322632076 date "2023-04-01" @default.
• W4322632076 modified "2023-10-16" @default.
• W4322632076 title "Naloxone expansion is not associated with increases in adolescent heroin use and injection drug use: Evidence from 44 US states" @default.
• W4322632076 cites W1791256761 @default.
• W4322632076 cites W1998386693 @default.
• W4322632076 cites W2064047117 @default.
• W4322632076 cites W2075709836 @default.
• W4322632076 cites W2078295263 @default.
• W4322632076 cites W2091600807 @default.
• W4322632076 cites W2286406976 @default.
• W4322632076 cites W2331803526 @default.
• W4322632076 cites W2472306680 @default.
• W4322632076 cites W2592507358 @default.
• W4322632076 cites W2735301415 @default.
• W4322632076 cites W2762190328 @default.
• W4322632076 cites W2787565376 @default.
• W4322632076 cites W2792522767 @default.
• W4322632076 cites W2803607233 @default.
• W4322632076 cites W2899316941 @default.
• W4322632076 cites W2907170513 @default.
• W4322632076 cites W2912131775 @default.
• W4322632076 cites W2941428213 @default.
• W4322632076 cites W2965786813 @default.
• W4322632076 cites W2974005807 @default.
• W4322632076 cites W2982218901 @default.
• W4322632076 cites W3017269474 @default.
• W4322632076 cites W3034962419 @default.
• W4322632076 cites W3037433655 @default.
• W4322632076 cites W3057931984 @default.
• W4322632076 cites W3061664158 @default.
• W4322632076 cites W3070625496 @default.
• W4322632076 cites W3124185412 @default.
• W4322632076 cites W3126362147 @default.
• W4322632076 cites W3134008650 @default.
• W4322632076 cites W3147447272 @default.
• W4322632076 cites W3157414770 @default.
• W4322632076 cites W3166544154 @default.
• W4322632076 cites W3173911966 @default.
• W4322632076 cites W3183252282 @default.
• W4322632076 cites W3202417152 @default.
• W4322632076 cites W3212856798 @default.
• W4322632076 cites W3213688921 @default.
• W4322632076 doi "https://doi.org/10.1016/j.drugpo.2023.103980" @default.
• W4322632076 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36863285" @default.
• W4322632076 hasPublicationYear "2023" @default.
• W4322632076 type Work @default.
• W4322632076 citedByCount "0" @default.
• W4322632076 crossrefType "journal-article" @default.
• W4322632076 hasAuthorship W4322632076A5006572902 @default.
• W4322632076 hasAuthorship W4322632076A5015719024 @default.
• W4322632076 hasAuthorship W4322632076A5032703621 @default.
• W4322632076 hasAuthorship W4322632076A5037098623 @default.
• W4322632076 hasAuthorship W4322632076A5053391308 @default.
• W4322632076 hasAuthorship W4322632076A5062381819 @default.
• W4322632076 hasAuthorship W4322632076A5068626512 @default.
• W4322632076 hasAuthorship W4322632076A5076335292 @default.
• W4322632076 hasAuthorship W4322632076A5078795152 @default.
• W4322632076 hasAuthorship W4322632076A5080186393 @default.
• W4322632076 hasAuthorship W4322632076A5082420499 @default.
• W4322632076 hasConcept C104863432 @default.
• W4322632076 hasConcept C105795698 @default.
• W4322632076 hasConcept C118552586 @default.
• W4322632076 hasConcept C126322002 @default.
• W4322632076 hasConcept C143095724 @default.
• W4322632076 hasConcept C144024400 @default.
• W4322632076 hasConcept C149923435 @default.
• W4322632076 hasConcept C151956035 @default.
• W4322632076 hasConcept C170493617 @default.
• W4322632076 hasConcept C2426938 @default.
• W4322632076 hasConcept C27403532 @default.
• W4322632076 hasConcept C2778750930 @default.
• W4322632076 hasConcept C2778767360 @default.
• W4322632076 hasConcept C2778903686 @default.
• W4322632076 hasConcept C2779148768 @default.
• W4322632076 hasConcept C2780035454 @default.
• W4322632076 hasConcept C2781063702 @default.
• W4322632076 hasConcept C2781072394 @default.
• W4322632076 hasConcept C3013748606 @default.
• W4322632076 hasConcept C33923547 @default.
• W4322632076 hasConcept C42219234 @default.
• W4322632076 hasConcept C44249647 @default.
• W4322632076 hasConcept C512399662 @default.
• W4322632076 hasConcept C529928208 @default.
• W4322632076 hasConcept C71924100 @default.
• W4322632076 hasConcept C77350462 @default.

• next